Paul Simms on a New Business Model for Pharma

20 minute watch

How web 2.0 thinking will enable a fresh generation of treatments.

Paul Simms was discussing the dangers of vaccine nationalism, the impact of Amazon Health and the nature of preventative medicine well before they became talking points. But his underlying mission has always been to introduce a new business model to mainstream pharma drug development and commercialisation.

Paul recently featured as a guest speaker at one of our FiveAndCo. Round Tables, proposing this platform-based model, so pharma leaders can get a head start.

See the full talk and interview below:

FiveAndCo. Round Tables are an opportunity for leaders in the Pharmaceutical and Life Sciences Industries to invest time in themselves, grow their leadership networks and their influence. We create an intimate setting in which to hear from an expert, discuss the issues and draw out practical insights.

More from the Knowledge Hub: